Tag:

Medicine/Public Health

Health

How to achieve global health equity without funding

by Chief Editor
written by Chief Editor

The Looming Funding Gap in Global Health: Navigating Towards Universal Coverage

Low- and middle-income countries (LMICs) have made significant strides in expanding health coverage over the past two decades, with a 60% increase in universal health coverage (UHC) reported. However, this progress is now threatened by a confluence of factors: declining external aid, rising inflation, increasing debt burdens, and the continued reliance on out-of-pocket payments for healthcare. This creates a critical dilemma for policymakers striving to maintain health equity and achieve UHC.

The Shrinking Pool of External Assistance

For years, LMICs have relied on assistance from donor nations and organizations to bolster their health systems. A sudden decline in this support, coupled with global economic headwinds, is forcing governments to reassess their financing strategies. The impact is particularly acute as many LMICs are also grappling with substantial debt-service obligations, further limiting their fiscal space.

The Burden of Out-of-Pocket Expenses

A significant challenge remains the high proportion of healthcare costs borne directly by individuals. These out-of-pocket payments can quickly lead to catastrophic health expenditures, pushing families into poverty when illness strikes. Protecting households from financial hardship is a central tenet of UHC, and requires innovative financing solutions.

A Six-Pronged Approach to Sustainable Financing

Addressing this complex situation requires a multifaceted approach. Experts suggest a practical agenda centered around six key strategies:

  1. Domestic Resource Mobilization: Governments must prioritize raising more funds domestically through equitable taxation systems, modest earmarked health levies, and improved public financial management.
  2. Risk Pooling & Diversification: Pooling risks across countries and utilizing a mix of public and private financing can reduce dependence on any single funding source.
  3. Debt-for-Health Swaps: Converting a portion of debt payments into investments in health systems and preparedness offers a novel pathway to increased funding.
  4. Strategic Partnerships: Collaboration with philanthropic organizations, faith-based groups, and private sector partners can unlock flexible resources and leverage existing delivery channels.
  5. Program Stabilization: Securing core programs through multiyear contracts protects essential services and safeguards the health workforce.
  6. Household Protection: Removing user fees for essential services, expanding community-based insurance schemes, and establishing safety nets for catastrophic costs are crucial for protecting vulnerable populations.

The Aging Population Factor

LMICs are experiencing rapid demographic shifts, with aging populations growing at a faster rate than in high-income countries. By 2050, 80% of the world’s older population will reside in LMICs. This demographic change necessitates building adequate and resilient health systems capable of meeting the unique needs of older adults, who are often overlooked in policy discussions.

Financing Mechanisms: A Closer Seem

Effective health financing relies on three core functions: revenue collection, pooling of resources, and purchasing of services. A recent systematic review highlights the need for continued research into these mechanisms within the context of LMICs, identifying both challenges and successful experiences to inform future reforms.

Did you know? Achieving UHC is not just about access to care; it’s also about financial protection. The COVID-19 pandemic underscored the fragility of health systems and the importance of preparedness.

The Post-Pandemic Landscape

The COVID-19 pandemic significantly disrupted progress towards primary health targets, exposing vulnerabilities in health systems worldwide. A post-pandemic recovery must prioritize strengthening health financing mechanisms and building more resilient systems capable of withstanding future shocks.

FAQ

Q: What is Universal Health Coverage (UHC)?
A: UHC aims to ensure that all people have access to the health services they need, when and where they need them, without facing financial hardship.

Q: Why are LMICs particularly vulnerable to health financing challenges?
A: LMICs often have limited domestic resources, high levels of debt, and a reliance on external aid, making them susceptible to economic shocks and fluctuations in funding.

Q: What role can the private sector play in UHC?
A: The private sector can contribute through partnerships with governments, providing flexible resources, and offering alternative delivery channels.

Pro Tip: Investing in national health schemes is a key strategy for strengthening and expanding healthcare provision even as preventing catastrophic out-of-pocket spending.

Learn more about Universal Health Coverage from the ILCUK report.

What strategies do you think are most crucial for achieving UHC in LMICs? Share your thoughts in the comments below!

0 comments
0 FacebookTwitterPinterestEmail
Entertainment

Short animated storytelling: designing science-based global health messages for extreme scalability

by Chief Editor
written by Chief Editor

The Future of Health Communication: Storytelling, AI, and the Fight Against Misinformation

For decades, public health campaigns have relied on facts, figures, and often, a stern tone. But a growing body of research, and the realities of the digital age, are forcing a rethink. The most effective health messaging isn’t about *what* you say, but *how* you say it. And increasingly, that “how” involves compelling stories, the power of visual media, and the intelligent application of artificial intelligence.

Beyond “Show, Don’t Tell”: The Rise of Wordless Storytelling

The principle of “show, don’t tell” isn’t new, but its impact is amplified in a world saturated with short-form video. Studies demonstrate that animated, wordless videos are remarkably effective at conveying health information, bypassing literacy barriers and cultural differences. A recent trial, for example, showed a 2-minute animated video demonstrating healthy cooking with a child increased intent to reduce added sugar consumption.1 This isn’t just about aesthetics; it’s about cognitive processing. Humans are wired for narrative. Stories engage emotions, improve retention, and encourage sharing.

Pro Tip: When crafting health messages, focus on depicting desired behaviors rather than simply listing risks. Instead of “Smoking causes cancer,” show a vibrant, active person enjoying life smoke-free.

AI as a Creative Partner: From Guidelines to Engaging Content

The potential of AI extends far beyond simply automating tasks. Generative AI tools are poised to revolutionize how health information is created and disseminated. Imagine feeding clinical guidelines into an AI and receiving, in return, a series of short, animated videos tailored to different demographics. This could dramatically lower the barrier for medical professionals to create accessible, engaging content. Early experiments are already underway, with teams exploring AI-powered virtual assistants to support community health workers, integrating storytelling videos in multiple languages.2

Social Media: Navigating the Minefield of Misinformation

Social media platforms are now primary sources of health information for millions. While this presents an unprecedented opportunity for reach, it also creates a breeding ground for misinformation. The challenge isn’t to abandon these platforms, but to strategically leverage them. The “CoVideo” animation, reaching over 15 million views within four months, demonstrates the potential for evidence-based messages to go viral.3 However, replicating that success requires partnerships with trusted institutions, influencers, and community organizations. Algorithm-informed targeting and micro-influencer collaborations will be crucial for amplifying reach.

Did you know? Content that evokes high-arousal emotions – awe, surprise, even humor – is significantly more likely to be shared on social media.4

The Power of Interdisciplinary Collaboration

Effective digital health storytelling isn’t a solo effort. It demands collaboration between diverse experts: behavioral scientists, animators, storytellers, clinicians, and crucially, individuals with lived experience. Incorporating the narratives of those directly affected by health issues ensures authenticity and resonance. For example, a recent study found that incorporating the perspectives of parents and children at risk of stigma significantly improved the efficacy of an animated video aimed at reducing stigma towards vulnerable youth.5

Designing for Inclusivity and Longevity

To maximize impact, health messages must be designed for inclusivity and durability. Characters intentionally devoid of specific cultural markers promote broad identification. Focusing on “evergreen” recommendations – handwashing, balanced nutrition – minimizes the need for constant updates. This principle is particularly important for reaching populations with limited literacy or language access. AI-powered translation and personalization tools promise to further enhance inclusivity, adapting content in real-time to individual needs.

The Hybrid Approach: Rigor and Real-World Impact

While randomized controlled trials (RCTs) remain the gold standard for evaluating interventions, they aren’t the whole story. Participants in online RCTs, while valuable, may not fully represent the general population. A hybrid approach – combining rigorous RCTs with A/B testing in live campaigns, natural experiments tracking organic spread, and analytics-based monitoring – is essential. This ensures both scientific validity and real-world relevance. AI-driven analytics and adaptive trial designs will further accelerate this process, enabling real-time optimization of messages.

Future Trends to Watch

  • Personalized Storytelling: AI algorithms will tailor narratives to individual preferences and risk factors.
  • Interactive Video: Viewers will be able to make choices within videos, influencing the storyline and receiving personalized recommendations.
  • Gamification: Health behaviors will be integrated into engaging game mechanics, incentivizing participation and tracking progress.
  • Virtual Reality (VR) and Augmented Reality (AR): Immersive experiences will allow users to practice healthy behaviors in safe, simulated environments.

FAQ

Q: Is wordless animation effective for complex health topics?
A: Yes, surprisingly so. Visual storytelling can simplify complex information and make it more accessible, even for nuanced topics.

Q: How can small public health organizations compete with larger institutions on social media?
A: Focus on niche audiences, collaborate with micro-influencers, and leverage data analytics to optimize your content strategy.

Q: What role does emotion play in health communication?
A: Emotion is crucial. Content that evokes emotion is more memorable, shareable, and likely to motivate behavior change.

Q: Is AI a threat to creative professionals in health communication?
A: Not necessarily. AI is best viewed as a tool to augment human creativity, automating repetitive tasks and freeing up professionals to focus on strategic thinking and storytelling.

What are your thoughts on the future of health communication? Share your insights in the comments below!

Explore more articles on health communication and digital media: [Link to related article 1] [Link to related article 2]

Subscribe to our newsletter for the latest insights and trends: [Link to newsletter signup]

1 Vandormael, A. et al. The effect of a wordless, animated, social media video intervention on COVID-19 prevention: online randomized controlled trial. JMIR Public Health Surveill. 7, e29060 (2021).

2 philanimentor.com

3 Vandormael, A. et al. The effect of a wordless, animated, social media video intervention on COVID-19 prevention: online randomized controlled trial. JMIR Public Health Surveill. 7, e29060 (2021).

4 Berger, J. & Milkman, K. L. What makes online content viral?. J. Mark. Res. 49, 192–205 (2012).

5 Amsalem, D., Greuel, M., Liu, S., Martin, A. & Adam, M. Effect of a short, animated storytelling video on transphobia among US parents: randomized controlled trial. JMIR Public Health Surveill. 11, e66496 (2025).

0 comments
0 FacebookTwitterPinterestEmail
Health

Personalized supervised and unsupervised intracranial sleep decoding during deep brain stimulation

by Chief Editor
written by Chief Editor

The Future of Parkinson’s Care: Decoding Sleep to Unlock Better Treatments

For years, Parkinson’s disease has been primarily understood through the lens of motor symptoms – tremors, rigidity, and slowness of movement. However, a growing body of research, fueled by advancements in neurotechnology and data science, is revealing a crucial, often overlooked dimension: sleep. And it’s not just *that* people with Parkinson’s experience sleep disturbances, but *how* those disturbances are intricately linked to disease progression and potential new therapeutic targets. This article dives into the cutting edge of this research, exploring how we’re moving beyond symptom management towards personalized, data-driven interventions.

The Deep Connection: Parkinson’s and Sleep Disruption

Sleep problems are incredibly common in Parkinson’s, affecting up to 80% of patients. These range from insomnia and restless legs syndrome to REM sleep behavior disorder (RBD) – a condition where individuals physically act out their dreams. Recent studies (Chen et al., 2024; Anjum et al., 2024) are demonstrating that these aren’t simply side effects of the disease or medication; they are actively involved in its progression. Specifically, disruptions in slow-wave sleep (SWS) – the deepest, most restorative stage of sleep – appear to correlate with faster motor and non-motor decline (Schreiner et al., 2019; Chen et al., 2024). Why? Sleep is when the brain clears metabolic waste (Xie et al., 2013) and consolidates memories (Klinzing et al., 2019), processes vital for neuronal health.

Pro Tip: Don’t dismiss sleep disturbances as just a part of aging. If you or a loved one with Parkinson’s is experiencing significant sleep issues, discuss them with a neurologist. Early intervention can make a substantial difference.

Decoding the Brain: Advanced Monitoring Technologies

Traditionally, diagnosing sleep disorders relied on polysomnography (PSG) – a comprehensive sleep study conducted in a lab. While accurate, PSG is cumbersome and expensive. The future lies in more accessible and continuous monitoring. Researchers are increasingly utilizing wearable devices like the Dreem headband (Arnal et al., 2022; Ravindran et al., 2025) and implantable sensors (Gilron et al., 2021) to gather detailed sleep data in real-world settings. These devices, coupled with sophisticated algorithms, can now accurately classify sleep stages and identify subtle patterns indicative of Parkinson’s-related sleep dysfunction.

But simply *collecting* data isn’t enough. The real breakthrough is in analyzing it. Techniques like Fast Fourier Transform (Welch, 1967) and machine learning, including LightGBM (Ke et al., 2017) and deep convolutional neural networks (Krizhevsky et al., 2012; Lawhern et al., 2018), are being employed to extract meaningful biomarkers from brain activity. For example, researchers are identifying specific patterns in basal ganglia oscillations during sleep that correlate with Parkinson’s symptoms (Mizrahi-Kliger et al., 2020; Cagle et al., 2024).

Adaptive Deep Brain Stimulation: A Personalized Approach

Deep brain stimulation (DBS) is a well-established treatment for Parkinson’s, but it’s often a “one-size-fits-all” approach. The exciting frontier is adaptive DBS (aDBS), which adjusts stimulation parameters in real-time based on a patient’s brain activity. Several studies (Oehrn et al., 2024; Stanslaski et al., 2022; Smyth et al., 2023) are demonstrating the potential of aDBS to target sleep-related brain activity. Imagine a system that detects when a patient enters SWS and subtly adjusts stimulation to enhance its restorative effects. This isn’t science fiction; clinical trials are underway.

Furthermore, researchers are exploring using local field potentials (LFPs) recorded directly from the subthalamic nucleus (STN) to predict sleep stages and optimize stimulation (Thompson et al., 2018; Christensen et al., 2019; Baumgartner et al., 2021). This level of personalization could dramatically improve both motor control and sleep quality.

Beyond DBS: Novel Therapeutic Targets

The insights gained from sleep research are also opening doors to entirely new therapeutic strategies. For instance, understanding the role of beta oscillations in Parkinson’s-related insomnia (Mizrahi-Kliger et al., 2020) could lead to targeted interventions to modulate these brainwaves. Similarly, identifying circadian rhythm disruptions (Mantovani et al., 2018) may pave the way for chronotherapy – timing medications to align with the body’s natural rhythms.

The development of closed-loop systems, utilizing neural coprocessors (Stanslaski et al., 2018, 2024), represents a significant step forward. These systems can continuously monitor brain activity, analyze data, and deliver targeted stimulation or medication adjustments without requiring constant physician intervention.

The Role of Artificial Intelligence and Data Augmentation

The sheer volume of data generated by these advanced monitoring technologies necessitates the use of artificial intelligence (AI). AI algorithms are being developed to automatically classify sleep stages (Eldele et al., 2021; Sekkal et al., 2022; Sri et al., 2022), identify subtle biomarkers, and predict treatment outcomes. Data augmentation techniques (Lashgari et al., 2020) are also crucial for improving the accuracy and robustness of these algorithms, particularly when dealing with limited datasets.

FAQ: Parkinson’s and Sleep

  • Q: Is RBD a sign of Parkinson’s? A: RBD can be an early indicator of Parkinson’s disease, often appearing years before motor symptoms.
  • Q: Can improving sleep improve Parkinson’s symptoms? A: Emerging research suggests that improving sleep quality can positively impact both motor and non-motor symptoms.
  • Q: What is adaptive DBS? A: Adaptive DBS is a form of DBS that adjusts stimulation parameters in real-time based on a patient’s brain activity.
  • Q: Are wearable sleep trackers accurate enough for Parkinson’s monitoring? A: While not as precise as PSG, newer wearable devices are becoming increasingly accurate and can provide valuable insights into sleep patterns.

The convergence of neuroscience, neurotechnology, and data science is revolutionizing our understanding of Parkinson’s disease. By focusing on the often-overlooked connection between sleep and disease progression, we are poised to unlock more effective, personalized treatments that improve the quality of life for millions affected by this condition.

Want to learn more about the latest advancements in Parkinson’s research? Explore our other articles on neurostimulation therapies and the role of biomarkers in disease management. Don’t forget to subscribe to our newsletter for updates on groundbreaking discoveries!

0 comments
0 FacebookTwitterPinterestEmail
Health

COVID-19 vaccination carries no association with childbirth rates in Sweden

by Chief Editor
written by Chief Editor

The Shifting Landscape of Pregnancy and COVID-19: What the Latest Research Reveals

The COVID-19 pandemic sparked a wave of misinformation, and few areas were as heavily impacted as pregnancy and reproductive health. From unfounded fears about vaccine-induced infertility to anxieties over birth outcomes, expectant parents faced a deluge of conflicting information. Now, as we move further from the acute phase of the pandemic, researchers are meticulously analyzing the data. What are the emerging trends, and what does the future hold for pregnancy and childbirth in a post-pandemic world?

Debunking the Myths: COVID-19 Vaccines and Fertility

One of the most persistent and damaging narratives was the claim that COVID-19 vaccines negatively impacted fertility. Thankfully, a growing body of evidence consistently refutes this. Studies like those referenced in Med Princ. Pr. (2024), a systematic review by Malik et al., demonstrate no link between vaccination and reduced conception rates. Further bolstering this, research from Manniche et al. (Int J. Risk Saf. Med, 2025) analyzing data from the Czech Republic, showed comparable success rates for pregnancies following vaccination.

Pro Tip: If you’re planning a pregnancy, the CDC and WHO continue to recommend COVID-19 vaccination for all eligible individuals, including those trying to conceive.

The Impact of COVID-19 Infection on Pregnancy Outcomes

While vaccines proved safe, the story is different for COVID-19 infection during pregnancy. Several studies indicate a potential increased risk of adverse outcomes. Vesco et al. (Obstet. Gynecol, 2024) found no increased risk of obstetric complications with antenatal vaccination, but other research points to a correlation between infection and increased risk of preterm birth and stillbirth. Sandoval et al. (BMC Med, 2025) specifically highlighted a link between prior COVID-19 infection and early pregnancy loss.

This underscores the importance of preventative measures – vaccination and boosters – to minimize the risk of infection during pregnancy. It also highlights the need for robust data infrastructure, as noted by Franklin et al. (JAMA, 2024), to facilitate timely and accurate research.

Beyond COVID-19: Broader Trends in Reproductive Health

The pandemic may have exacerbated existing trends in reproductive health. Winkler-Dworak et al. (Hum. Reprod. Open, 2024) observed birth rate declines linked to pandemic-related policy interventions, vaccination programs, and economic uncertainty. These factors, combined with pre-existing societal shifts, contribute to declining fertility rates in many developed nations.

Did you know? Sweden, despite its generous family policies, has also experienced fluctuating fertility rates, influenced by factors like changing societal norms and women’s increased participation in the workforce (Hoem & Hoem, 1996).

Addressing Misinformation and Building Trust

The spread of misinformation during the pandemic highlighted the critical need for effective communication strategies. Winters et al. (Sci. Rep, 2025) demonstrated the potential of innovative approaches, like audio dramas, to debunk vaccine misinformation in Ghana. However, combating misinformation requires a multi-pronged approach, including proactive public health messaging, collaboration with social media platforms, and empowering healthcare providers to address patient concerns.

The recent statements by figures like RFK Jr. ( CIDRAP News, 2025) emphasizing against COVID vaccines for healthy children and pregnant women, demonstrate the continued presence of misinformation and the need for continued vigilance.

Looking Ahead: The Future of Pregnancy Care

The future of pregnancy care will likely involve a greater emphasis on personalized medicine, leveraging data to identify and mitigate individual risks. Improved surveillance systems, like those discussed by Hui et al. (Women Birth, 2025) for monitoring suboptimal care factors, will be crucial. Furthermore, addressing systemic inequities in healthcare access will be paramount to ensuring positive outcomes for all expectant parents.

Frequently Asked Questions

  • Is the COVID-19 vaccine safe during pregnancy? Yes, major health organizations recommend COVID-19 vaccination during pregnancy to protect both the mother and the baby.
  • Does COVID-19 infection affect pregnancy? COVID-19 infection during pregnancy has been linked to an increased risk of preterm birth and other complications.
  • What can I do to protect myself and my baby? Get vaccinated and boosted against COVID-19, practice good hygiene, and consult with your healthcare provider for personalized advice.
  • Where can I find reliable information about COVID-19 and pregnancy? Refer to the CDC (https://www.cdc.gov/), WHO (https://www.who.int/), and your healthcare provider.

Want to learn more? Explore our articles on prenatal care and vaccine safety. Share your thoughts and questions in the comments below!

0 comments
0 FacebookTwitterPinterestEmail
Health

Association between the lactate to creatinine ratio and hospital mortality in patients with pediatric sepsis: a cohort study

by Chief Editor
written by Chief Editor

The Future of Pediatric Sepsis Prediction: Beyond Traditional Scores

Pediatric sepsis remains a leading cause of mortality in children worldwide. Early and accurate identification is crucial, but current diagnostic tools often fall short. A recent study, leveraging data from the PLOS ONE dataset (“Data from: Validating the performance of organ dysfunction scores in children with infection: A cohort study,” https://doi.org/10.1371/journal.pone.0306172), highlights the ongoing quest for better predictive markers. This research, conducted at the Children’s Hospital of Chongqing Medical University, focused on the lactate-to-creatinine ratio (LCR) as a potential indicator of hospital mortality. But the story doesn’t end there. The future of pediatric sepsis prediction lies in a convergence of advanced analytics, personalized medicine, and real-time monitoring.

The Limitations of Current Sepsis Scoring Systems

Traditional organ dysfunction scores, like those used in the Phoenix Sepsis Score (PSS), are valuable but imperfect. The Chongqing study underscores challenges in applying these scores consistently, particularly when age-specific data is lacking – as seen with cardiovascular subscores in infants under two. Relying on surrogate indicators, like lactate levels or vasopressor use, introduces potential inaccuracies. Furthermore, these scores often rely on retrospective data analysis, meaning they identify risk *after* the critical period has begun. The goal is to move towards proactive, predictive modeling.

The Rise of Machine Learning and AI

Machine learning (ML) algorithms are poised to revolutionize sepsis detection. Unlike traditional scoring systems, ML can analyze vast datasets – encompassing vital signs, lab results, genetic predispositions, and even environmental factors – to identify subtle patterns indicative of impending sepsis. Researchers are already developing algorithms that outperform existing scores in predicting sepsis onset and mortality. For example, a 2023 study published in Critical Care Medicine demonstrated an AI model achieving 92% accuracy in predicting sepsis 24 hours before clinical manifestation, significantly higher than the performance of the Sequential Organ Failure Assessment (SOFA) score.

Pro Tip: The key to successful ML implementation isn’t just the algorithm itself, but the quality and completeness of the data it’s trained on. Standardized data collection protocols and robust data governance are essential.

The Promise of Real-Time Monitoring and Wearable Sensors

The future isn’t just about analyzing historical data; it’s about continuous, real-time monitoring. Wearable sensors, capable of tracking vital signs like heart rate, respiratory rate, and skin temperature, are becoming increasingly sophisticated and affordable. These devices, coupled with advanced analytics, can provide an early warning system for sepsis, particularly in high-risk populations. Imagine a continuous stream of data feeding into an AI model, alerting clinicians to subtle changes that might otherwise go unnoticed. This is particularly relevant for children recently discharged from the PICU or those with chronic conditions.

Personalized Medicine and Biomarker Discovery

Sepsis isn’t a one-size-fits-all condition. Genetic factors, underlying health conditions, and even the specific pathogen causing the infection can influence a child’s response. Personalized medicine, tailoring treatment based on an individual’s unique characteristics, is gaining traction. This requires identifying novel biomarkers – measurable indicators of a biological state – that can predict sepsis risk and guide treatment decisions. Research is focusing on biomarkers beyond traditional measures like procalcitonin and C-reactive protein, exploring the role of genomics, proteomics, and metabolomics in sepsis pathogenesis.

Did you know? The LCR, as investigated in the Chongqing study, is gaining attention as a potential early biomarker due to its association with tissue hypoperfusion, a hallmark of sepsis.

The Role of Telemedicine and Remote Monitoring

Telemedicine is expanding access to specialized care, particularly in rural or underserved areas. Remote monitoring technologies allow clinicians to track patients’ conditions remotely, enabling earlier intervention and potentially reducing the need for hospital admission. This is especially valuable for children with complex medical needs who may be at higher risk of sepsis. However, ensuring equitable access to these technologies and addressing concerns about data privacy and security are crucial.

Addressing Ethical Considerations and Data Privacy

The increasing use of AI and data analytics in healthcare raises important ethical considerations. Protecting patient privacy, ensuring data security, and avoiding algorithmic bias are paramount. Transparency in algorithm development and deployment is essential to build trust and ensure equitable access to care. Robust regulatory frameworks are needed to govern the use of these technologies and safeguard patient rights.

Frequently Asked Questions (FAQ)

Q: What is the lactate-to-creatinine ratio (LCR)?
A: The LCR is a calculation (lactate level divided by creatinine level) used to assess tissue perfusion. Elevated levels can indicate impaired oxygen delivery, a common feature of sepsis.

Q: How can machine learning help with sepsis detection?
A: ML algorithms can analyze complex datasets to identify subtle patterns indicative of sepsis, potentially predicting its onset before traditional methods.

Q: What are the challenges of using wearable sensors for sepsis monitoring?
A: Challenges include data accuracy, ensuring patient compliance, and integrating sensor data with existing clinical workflows.

Q: Is AI likely to replace doctors in sepsis diagnosis?
A: No. AI is intended to *augment* clinical decision-making, not replace it. Doctors will continue to play a vital role in interpreting data and providing patient care.

The future of pediatric sepsis prediction is bright, driven by technological advancements and a growing understanding of the disease. By embracing these innovations and addressing the associated challenges, we can significantly improve outcomes for children at risk of this life-threatening condition.

Want to learn more about advancements in pediatric critical care? Explore our other articles on innovative treatment strategies.

0 comments
0 FacebookTwitterPinterestEmail
Tech

Artificial intelligence for public health can harness data for healthier populations

by Chief Editor
written by Chief Editor

The AI-Powered Future of Healthcare: Beyond Diagnosis

Artificial intelligence is no longer a futuristic promise in healthcare; it’s rapidly becoming a clinical reality. Recent research, highlighted in publications like NEJM AI (Ma et al., 2024) and Nature (Kraemer et al., 2025), demonstrates AI’s growing capabilities in areas far beyond initial expectations. We’re moving past simply assisting with diagnosis to a future where AI proactively manages patient health, personalizes treatment, and even predicts outbreaks before they occur.

Predictive Healthcare: Stopping Illness Before It Starts

One of the most exciting frontiers is predictive healthcare. AI algorithms, trained on vast datasets of patient information – including genomics, lifestyle factors, and environmental exposures (VoPham et al., 2018) – can identify individuals at high risk for specific diseases. This isn’t about fortune-telling; it’s about recognizing patterns humans might miss.

For example, AI is being used to predict the likelihood of heart failure readmission with remarkable accuracy. Hospitals are now using these insights to proactively intervene with at-risk patients, providing more intensive monitoring and tailored support. This reduces hospital readmissions, improves patient outcomes, and lowers healthcare costs. The work by Zeng et al. (2025) in JAMA showcases promising results in this area.

Pro Tip: Data privacy is paramount. Successful implementation of predictive healthcare relies on robust data security measures and transparent patient consent protocols.

Personalized Medicine: Tailoring Treatment to the Individual

The “one-size-fits-all” approach to medicine is becoming obsolete. AI is enabling a new era of personalized medicine, where treatments are tailored to an individual’s unique genetic makeup, lifestyle, and disease characteristics. This is particularly impactful in oncology, where AI can analyze tumor genomes to identify the most effective targeted therapies.

Li et al. (2024) in Nat Med detail advancements in using AI to predict patient response to immunotherapy, a powerful but often unpredictable cancer treatment. By identifying biomarkers that indicate likely responders, clinicians can avoid subjecting non-responders to unnecessary and potentially harmful side effects.

AI-Driven Drug Discovery: Accelerating Innovation

Developing new drugs is a notoriously slow and expensive process. AI is dramatically accelerating this process by identifying potential drug candidates, predicting their efficacy, and optimizing clinical trial design. AI algorithms can sift through millions of compounds, predicting their interactions with biological targets far faster than traditional methods.

Companies like Insilico Medicine are already using AI to discover and develop novel drugs for a range of diseases. This isn’t just about speed; it’s about identifying drugs that might have been overlooked by traditional screening methods. The potential to address previously untreatable conditions is immense.

The Rise of the ‘Digital Twin’ in Healthcare

Imagine a virtual replica of a patient – a “digital twin” – that can be used to simulate the effects of different treatments before they are administered in the real world. This is becoming a reality thanks to advances in AI and machine learning. Digital twins can incorporate a patient’s medical history, genetic information, and real-time physiological data to create a highly personalized model.

Clinicians can then use this model to test different treatment scenarios, predict potential side effects, and optimize treatment plans. This approach promises to revolutionize chronic disease management and improve patient safety.

Addressing the Challenges: Bias, Trust, and Integration

Despite the immense potential, several challenges must be addressed to ensure the responsible and equitable implementation of AI in healthcare. One major concern is bias in algorithms. If the data used to train an AI model is biased, the model will perpetuate and even amplify those biases, leading to disparities in care.

Building trust is also crucial. Patients and clinicians need to understand how AI algorithms work and be confident in their accuracy and reliability. Transparency and explainability are key. Finally, integrating AI into existing healthcare workflows can be complex and requires careful planning and investment. Reddy et al. (2020) in JAMIA highlight the importance of user-centered design in AI implementation.

The Future is Now: AI and the Evolving Role of Healthcare Professionals

AI isn’t intended to replace healthcare professionals; it’s designed to augment their capabilities. The role of doctors and nurses will evolve to focus on tasks that require uniquely human skills, such as empathy, communication, and complex decision-making. AI will handle the more routine and data-intensive tasks, freeing up clinicians to spend more time with patients.

The integration of AI into healthcare is not merely a technological shift; it’s a fundamental transformation of how we approach health and wellness. As AI continues to evolve, we can expect to see even more innovative applications that improve patient outcomes, reduce healthcare costs, and create a healthier future for all.

FAQ

Q: Is AI in healthcare secure?
A: Security is a top priority. Healthcare organizations are implementing robust data encryption, access controls, and privacy protocols to protect patient information.

Q: Will AI take doctors’ jobs?
A: No. AI will augment doctors’ abilities, allowing them to focus on more complex tasks and patient interaction.

Q: How can I learn more about AI in healthcare?
A: Explore resources from organizations like the National Institutes of Health (NIH) and the Food and Drug Administration (FDA), and follow leading researchers in the field.

Did you know? AI is being used to analyze medical images – like X-rays and MRIs – with greater accuracy than human radiologists in some cases.

What are your thoughts on the future of AI in healthcare? Share your comments below!

0 comments
0 FacebookTwitterPinterestEmail
Health

Aflibercept 8 mg treat-and-extend pathway for the treatment of neovascular age-related macular degeneration: guidance from a UK expert panel

by Chief Editor
written by Chief Editor

The Growing Influence of Pharma Funding in Ophthalmology: What Does the Future Hold?

A recent disclosure of financial ties within the ophthalmology field – specifically, a list of researchers receiving grants and honoraria from major pharmaceutical companies like AbbVie, Bayer, and Roche – highlights a trend that’s been quietly accelerating for years. While not inherently negative, the sheer scale of these relationships raises important questions about potential biases, research priorities, and the future direction of eye care. This isn’t about questioning the integrity of individual researchers, but rather examining the systemic implications of such widespread industry funding.

The Current Landscape: A Web of Financial Connections

The disclosed relationships, spanning numerous key opinion leaders and Eye editorial board members, aren’t isolated incidents. They reflect a broader pattern in medical research. Pharmaceutical companies invest heavily in research and development, and often collaborate with leading academics to test and promote their products. According to a 2023 report by the Pew Research Center, industry funding accounted for over 75% of all biomedical research funding in the US. This dependence creates a complex dynamic.

The disclosed funding covers a range of activities: travel grants (covering expenses to attend conferences and meetings), honoraria (payments for speaking engagements and advisory board roles), and research funding (direct financial support for studies). While transparency is crucial – as demonstrated by this disclosure – the volume of these connections warrants closer scrutiny.

Shifting Research Priorities: Where Does the Money Lead?

One key concern is the potential for industry funding to influence research priorities. Pharmaceutical companies naturally focus on areas where they can generate profit. This can lead to an overemphasis on developing treatments for chronic conditions requiring long-term medication, while neglecting research into preventative measures or cures. For example, significant investment exists in therapies for age-related macular degeneration (AMD) and diabetic retinopathy, but comparatively less funding goes towards understanding the root causes of these conditions or exploring preventative lifestyle interventions.

Pro Tip: When evaluating medical research, always consider the funding source. Look for independent studies funded by non-profit organizations or government agencies.

The Rise of Personalized Medicine and Gene Therapy: New Funding Frontiers

The future of ophthalmology is increasingly focused on personalized medicine and gene therapy. These cutting-edge fields require substantial investment, making them particularly attractive to pharmaceutical companies. We’re already seeing this play out with the approval of Luxturna, a gene therapy for a rare form of inherited retinal dystrophy, developed by Spark Therapeutics (now part of Roche). Expect to see increased industry funding directed towards similar therapies for other genetic eye diseases.

However, the high cost of these treatments raises ethical concerns about accessibility and affordability. Industry funding may prioritize development for markets with higher purchasing power, potentially exacerbating health disparities.

Transparency and Mitigation Strategies: Building Trust

Increased transparency, like the disclosure discussed here, is a vital first step. However, it’s not enough. Several strategies can help mitigate potential biases:

  • Independent Research Funding: Increased funding from government agencies (like the National Eye Institute in the US) and non-profit organizations is crucial.
  • Data Sharing: Encouraging researchers to share their data openly can allow for independent verification of results.
  • Conflict of Interest Policies: Strengthening conflict of interest policies at academic institutions and medical journals.
  • Patient Advocacy: Empowering patient advocacy groups to play a more active role in shaping research agendas.

Did you know? Many medical journals now require authors to disclose all sources of funding and potential conflicts of interest.

The Role of Digital Health and AI: A Potential Game Changer

The emergence of digital health technologies, such as AI-powered diagnostic tools and remote monitoring systems, could disrupt the traditional pharmaceutical-dominated model. These technologies often require less upfront investment and can be developed by smaller, independent companies. However, even in this space, we’re seeing increasing interest from pharmaceutical giants looking to integrate digital solutions into their portfolios.

FAQ

Q: Is it unethical for researchers to accept funding from pharmaceutical companies?
A: Not necessarily. Transparency and careful management of conflicts of interest are key. Accepting funding doesn’t automatically invalidate research, but it requires scrutiny.

Q: How can I find unbiased information about eye health?
A: Look for information from reputable sources like the National Eye Institute (https://www.nei.nih.gov/), the American Academy of Ophthalmology (https://www.aao.org/), and your own ophthalmologist.

Q: What is a conflict of interest?
A: A conflict of interest occurs when a researcher has a financial or personal relationship that could potentially bias their research.

Q: Will increased industry funding lead to higher drug prices?
A: It’s a possibility. Industry funding often aims to recoup investment through profitable products, which can contribute to higher prices.

The future of ophthalmology will be shaped by a complex interplay of scientific innovation, financial investment, and ethical considerations. Staying informed and critically evaluating information are essential for both healthcare professionals and patients.

Want to learn more? Explore our articles on the latest advancements in AMD treatment and preventative strategies for diabetic retinopathy.

Share your thoughts! What role do you think pharmaceutical companies should play in medical research? Leave a comment below.

0 comments
0 FacebookTwitterPinterestEmail
Health

SLEEPYLAND: trust begins with fair evaluation of automatic sleep staging models

by Chief Editor
written by Chief Editor

The Future of Sleep Science: AI, Data, and Personalized Rest

For decades, understanding sleep has been a complex puzzle. Traditionally, sleep staging – identifying whether someone is in light sleep, deep sleep, REM, or awake – relied on painstaking manual analysis by trained professionals. But a revolution is underway, driven by artificial intelligence, massive datasets, and a growing recognition of sleep’s profound impact on overall health. This isn’t just about better sleep trackers; it’s about fundamentally changing how we diagnose, treat, and even prevent sleep disorders.

The Rise of Automated Sleep Scoring

The core of this shift is automated sleep scoring. References like the 2017 AASM Scoring Manual updates (Berry et al., 2017) provide the standardized guidelines, but applying them is time-consuming. AI, particularly deep learning models like those explored by Fiorillo et al. (2019, Sleep Medicine Reviews) and Sleeptransformer (Phan et al., 2022), are now achieving accuracy comparable to human experts. This isn’t about replacing sleep technicians; it’s about augmenting their capabilities and making sleep analysis accessible to more people.

Pro Tip: While automated scoring is improving rapidly, it’s crucial to remember that algorithms are only as good as the data they’re trained on. Bias in training data can lead to inaccurate results for certain populations, a concern highlighted by Bechny et al. (2023, 2024).

The Power of Big Data and Sleep Research Resources

The development of robust AI models requires vast amounts of data. Fortunately, initiatives like the National Sleep Research Resource (Zhang et al., 2018, 2024) are creating publicly available datasets, fostering collaboration and accelerating research. Similarly, the Bern Sleep-Wake Registry (Calle et al., 2018) and Dreem open datasets (Guillot et al., 2020) are providing valuable resources for scientists. These resources are moving us beyond small, isolated studies to large-scale analyses that can reveal subtle patterns and personalized insights.

Did you know? The PhysioNet database (Goldberger et al., 2000) has been a cornerstone of physiological signal research for over two decades, and continues to expand its sleep-related data offerings.

Beyond Accuracy: Bias Detection and Algorithmic Fairness

As AI becomes more integrated into healthcare, ensuring fairness and mitigating bias is paramount. Recent work by Bechny et al. (2025) focuses on developing frameworks to quantify algorithmic bias in sleep scoring, recognizing that algorithms can perpetuate existing health disparities. This is particularly important given documented differences in sleep patterns across racial and ethnic groups (Chen et al., 2015).

Personalized Sleep Medicine: A Future Tailored to You

The ultimate goal is personalized sleep medicine. Instead of a one-size-fits-all approach, treatment will be tailored to an individual’s unique physiology, genetics, and lifestyle. This will involve:

  • Multimodal Data Integration: Combining EEG data with other physiological signals (heart rate variability, respiratory patterns, movement) and even behavioral data (activity levels, diet, stress levels).
  • Predictive Modeling: Using machine learning to predict an individual’s risk of developing sleep disorders or experiencing negative health consequences from poor sleep.
  • Closed-Loop Systems: Developing systems that automatically adjust interventions (e.g., CPAP pressure, light exposure) based on real-time sleep data.

The development of foundation models, like the multimodal sleep foundation model by Thapa et al. (2025), represents a significant step towards this future. These models, trained on massive datasets, can be adapted to a wide range of sleep-related tasks.

The Role of Open-Source Tools and Collaboration

Open-source software is playing a crucial role in democratizing sleep research. Tools like Sleep (Combrisson et al., 2017) and U-Sleep (Perslev et al., 2021) provide researchers with accessible and customizable platforms for analyzing sleep data. This collaborative spirit is essential for accelerating innovation.

Frequently Asked Questions

Q: Will AI replace sleep specialists?
A: No. AI will augment their abilities, automating tedious tasks and providing more data-driven insights, allowing specialists to focus on complex cases and patient care.

Q: How accurate are current AI sleep scoring algorithms?
A: Accuracy is constantly improving, with some algorithms achieving substantial agreement with human experts, but it varies depending on the algorithm and the quality of the data.

Q: What are the ethical considerations of using AI in sleep medicine?
A: Bias in algorithms, data privacy, and the potential for misdiagnosis are key ethical concerns that need to be addressed.

Q: Where can I find publicly available sleep datasets?
A: The National Sleep Research Resource, Bern Sleep-Wake Registry, and Dreem open datasets are excellent starting points.

The future of sleep science is bright. By harnessing the power of AI, big data, and open collaboration, we are poised to unlock the secrets of sleep and improve the health and well-being of millions.

Want to learn more about sleep technology? Explore our other articles on wearable sleep trackers and the impact of blue light on sleep.

0 comments
0 FacebookTwitterPinterestEmail
Health

The role of reward-related brain activity in response to treatment and later depression severity: data from a randomized controlled trial in early adolescents with anxiety disorders

by Chief Editor
written by Chief Editor

Rewiring the Teenage Brain: Future Trends in Mental Health Treatment

As a seasoned journalist specializing in mental health, I’ve spent years sifting through research and speaking with experts. The landscape of adolescent mental health is evolving rapidly, and the future holds exciting (and sometimes challenging) developments. This isn’t just about identifying problems; it’s about understanding how the teenage brain works and crafting treatments that resonate with its unique vulnerabilities and potential.

The Neural Basis of Anxiety and Depression: A New Frontier

The references provided ([1-7]) highlight a critical shift: understanding anxiety and depression through the lens of neurobiology. We’re moving beyond simplistic diagnoses and delving into the neural circuits at play. Specifically, research is focusing on:

  • Reward Processing: How teens experience and respond to rewards. Dysfunctional reward processing is increasingly linked to depression [15].
  • Threat Detection: The brain’s response to perceived threats. Understanding these mechanisms can inform more effective interventions [28].
  • Cognitive Control: The ability to manage thoughts and emotions. The frontoparietal control system plays a key role [29].

Did you know? The brain undergoes significant development during adolescence, making this period a critical window for intervention. (See [8, 9])

Cognitive Behavioral Therapy (CBT) and Beyond

CBT remains a cornerstone of treatment. However, future trends suggest:

  • Personalized CBT: Tailoring therapy to the individual’s specific neural profile. This may involve using neuroimaging to guide treatment [26].
  • Integrating Positive Psychology: Incorporating elements of positive affect to enhance treatment outcomes [18].
  • Digital Therapeutics: Leveraging technology for accessible and engaging interventions. This could include gamified CBT programs.

Pro tip: Look for therapists trained in the latest evidence-based practices, including those incorporating neuroscience principles.

The Role of the Default Mode Network (DMN)

The DMN, a network active when the brain is at rest, is now recognized as a key player in mental health. Increased DMN activity has been observed in socially anxious individuals [33]. Research will likely:

  • Explore DMN Dysfunction: Investigating how DMN irregularities contribute to anxiety and depression [51].
  • Target DMN with Therapy: Developing therapies designed to modulate DMN activity, potentially improving outcomes.

For more on how CBT can affect the brain, read our related article: The Brain on CBT: How Therapy Rewires Your Mind.

Early Intervention: A Proactive Approach

Preventative measures are crucial. Future trends include:

  • Identifying Early Risk Factors: Research into developmental risk factors like intolerance of uncertainty [48].
  • School-Based Programs: Expanding mental health services within schools to identify and support at-risk teens.

Consider the findings of Marwood et al. (2018), for example, which point to the significance of neural mechanisms in the response to psychotherapy.

The Power of Data and Assessment

More accurate and reliable assessments are crucial.

  • Advanced Neuroimaging: Employing fMRI and other technologies to gain a more detailed understanding of neural mechanisms [24].
  • Developing Sophisticated Predictive Models: Using machine learning to predict treatment outcomes and identify those who may benefit the most [55].
  • Standardized Assessment Tools: Using established tools like the Pediatric Anxiety Rating Scale (PARS) [36, 37] or the Mood and Feelings Questionnaire (MFQ) [38], alongside new developments.

Addressing Co-Occurring Conditions

Many teens struggle with multiple mental health challenges.

  • Integrated Treatment Approaches: Therapies that consider the interplay between anxiety, depression, and other disorders.
  • Focus on Comorbidities: Research targeted at understanding how disorders co-occur and develop tailored treatment plans.

For further reading, explore the latest meta-analyses on treatment effectiveness for anxiety disorders in high-income countries, such as those conducted by Barican et al. [1] and Bandelow et al. [3].

Frequently Asked Questions (FAQ)

Q: Is technology replacing therapists?

A: No, but it’s enhancing access to care and personalizing treatments. Therapists remain essential.

Q: Are medications always necessary for anxiety and depression?

A: No. Therapy, particularly CBT, is often highly effective. Medication may be helpful in some cases, and a combination of both is sometimes used.

Q: How can I find a therapist specializing in adolescent mental health?

A: Your pediatrician, school counselor, or insurance provider can provide referrals. Look for licensed professionals with experience working with teens.

What’s Next?

The future of adolescent mental health treatment is bright, with the promise of more effective, personalized care. By staying informed and advocating for these advancements, we can help create a healthier future for our teens. What are your thoughts on these trends? Share your comments and insights below!

Explore more: Check out our other articles on mental health treatment for additional resources and actionable advice.

0 comments
0 FacebookTwitterPinterestEmail
World

Post-conflict nutritional status of school-age children in North Wollo zone, Northeast Ethiopia: a multi-center cross-sectional study | BMC Public Health

by Chief Editor
written by Chief Editor 
<h2 class="article-title">Unveiling Tomorrow's Health: Trends Shaping Child Nutrition and Undernutrition Challenges</h2>

<p>The study of child nutrition and undernutrition is constantly evolving. It’s a complex field influenced by a myriad of factors, from geopolitical stability to advancements in medical technology. Understanding the current landscape – like the community-based study in Ethiopia, as provided – is crucial for anticipating future trends and developing effective interventions. Let's delve into the key areas that will shape the future of child health.</p>

<h3 class="article-subheading">Geopolitical Shifts and Nutritional Vulnerability</h3>

<p>The study area in Northeast Ethiopia, significantly affected by conflict, highlights the profound impact of geopolitical events on child health. Conflict zones often experience increased undernutrition due to disrupted food supplies, displacement, and limited access to healthcare. </p>

<p><b>Did you know?</b> According to the World Food Programme, conflict is a major driver of food insecurity globally, exacerbating existing nutritional challenges, especially for children.</p>

<h3 class="article-subheading">The Rise of Data-Driven Solutions</h3>

<p>The study's reliance on anthropometric measurements and data analysis, including the use of WHO Anthro software, points towards a future where data plays a pivotal role. Advanced analytical techniques and real-time data collection will revolutionize how we identify and address nutritional deficiencies. For example, remote monitoring using mobile technology could track a child’s nutritional status in real-time, leading to quicker interventions.</p>

<p><b>Pro Tip:</b> Consider the role of precision nutrition in child health. Tailoring dietary recommendations based on individual needs, genetic predispositions, and environmental factors could significantly improve outcomes. Explore research on personalized nutrition strategies.</p>

<h3 class="article-subheading">Community-Based Interventions: A Focus on Accessibility</h3>

<p>The study's community-based approach, involving selection of specific areas and households, underscores the importance of localized interventions. Future strategies will need to be tailored to specific communities and cultural contexts. This requires understanding local food practices, beliefs, and access to resources. Strengthening local health systems and empowering community health workers will be essential.</p>

<p><b>Case Study:</b> The success of community-based nutrition programs in countries like Bangladesh, which have focused on empowering women and strengthening local food production, serves as a valuable model. Read more about these success stories on the [World Health Organization website](https://www.who.int/).</p>

<h3 class="article-subheading">Precision Anthropometry and Advanced Diagnostics</h3>

<p>While the study uses standard anthropometric measurements (weight and height), future trends will likely incorporate more sophisticated methods. Advanced imaging techniques could allow for more precise assessment of body composition. Innovations in diagnostic tools will enable earlier and more accurate detection of micronutrient deficiencies, such as deficiencies of iron, vitamin A, or iodine.</p>

<p><b>Related Keyword:</b> *Child Growth Monitoring* - Explore the evolution of growth charts and techniques.</p>

<h3 class="article-subheading">The Role of Technology in Nutrition Education</h3>

<p>Technology offers innovative avenues for disseminating nutrition information. Interactive mobile apps, virtual reality simulations, and online educational platforms can empower parents and caregivers with knowledge about proper feeding practices, balanced diets, and the importance of early childhood nutrition. The use of technology will also enable better tracking of intervention programs and improved communication between healthcare providers and families. Explore advancements in mobile health or mHealth platforms.</p>

<h3 class="article-subheading">Ethical Considerations and Informed Consent</h3>

<p>The ethical considerations highlighted in the study (informed consent, confidentiality) are paramount. As we move forward, it is critical that interventions are carried out with respect for individual rights and cultural sensitivity. This ensures transparency, accountability, and that the focus remains on the wellbeing of the children.</p>

 <p><b>Related Keyword:</b> *Informed consent in health research* - Understand ethical guidelines for children's health studies.</p>

<h2 class="article-subheading">Frequently Asked Questions (FAQ)</h2>

<div class="faq-section">
  <div class="faq-item">
    <p><strong>What is stunting?</strong></p>
    <p>Stunting refers to a child being too short for their age, typically due to chronic malnutrition.</p>
  </div>

  <div class="faq-item">
    <p><strong>What is thinness?</strong></p>
    <p>Thinness, also known as wasting, indicates that a child is too thin for their height, often a result of acute malnutrition.</p>
  </div>

  <div class="faq-item">
    <p><strong>What are the key indicators for undernutrition?</strong></p>
    <p>The primary indicators of undernutrition include stunting, thinness, and underweight, which are evaluated by comparing a child's measurements to established growth references.</p>
  </div>

  <div class="faq-item">
    <p><strong>Why is early intervention important?</strong></p>
    <p>Early intervention is crucial because malnutrition during critical periods of child development can have irreversible consequences on physical and cognitive development.</p>
  </div>
</div>

<p>The future of child nutrition is promising. By embracing data-driven solutions, fostering community engagement, and leveraging technological advancements, we can build a healthier future for children worldwide. What challenges do you foresee in implementing these strategies? Share your thoughts in the comments below! For related reading, check out our article on [childhood obesity]([Insert a link to relevant article]).</p>
0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts